Efrat Dotan, MD, MTR
Clinical Professor of Medicine (Hematology-Oncology)
Department: Medicine
Contact information
Penn Medicine Lancaster General Health
2100 Harrisburg Pike
Lancaster, PA 17601
2100 Harrisburg Pike
Lancaster, PA 17601
Education:
BS (Medical Sciences )
Technion, Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, cum laude , 1997.
MD (Medicine)
Technion, Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, cum laude, 2002.
MTR (Masters of Translational Research )
University of Pennsylvania , 2013.
Permanent linkBS (Medical Sciences )
Technion, Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, cum laude , 1997.
MD (Medicine)
Technion, Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, cum laude, 2002.
MTR (Masters of Translational Research )
University of Pennsylvania , 2013.
Selected Publications
Dotan E, Catalano PJ, Lenchik L, Boutin R, Yao X, Ohr J, Lim KH, Vijayvergia N, Chandana SR, Kalyan A, Dunne RF, Zhen DB, Li D, Simon MA, Berlin J, Wagner LI, O'Dwyer PJ.: Randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT). ECOG-ACRIN Annual Meeting, Fort Lauderdale, FL. Nov 2024 Notes: "Oral Presentation"Sedrak MS, Sun CL, Bae M, Freedman RA, Magnuson A, O'Connor T, Moy B, Wildes TM, KlepinHD, Chapman AE, Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Muss HB, Cohen HJ, Gross CP, Ji J.: Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study J Cancer Surviv 18(4): 1131-1143. Aug 2024.
Persley CJ, Baumgart M, Halmos B, Dotan E. : Cancer rarely travels Alone: Addressing the accumulation of risk and early mortality form older adults with advanced lung cancer. J Geriatr Oncol 15(6): 101579, Jul 2024.
Ioffe D, Bhatia-Patel SC, Gandhi S, Hamad EA, Dotan E.: Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer: JACC Family Series JACC CardioOncol 6(2): 143-158. Apr 2024.
Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials : Kaur M, Frahm F, Lu Y, Ascha MS, Guadamuz JS, Dotan E, Gottesman A, Leybovich BC, Sondhi A,Zhao Y, Meropol NJ, Royce TJ. NEJM Evid 3(4): EVIDoa2300236. Apr 2024.
JiJ, Bae M, Sun CL, Wildes TM, Freedman RA, Magnuson A, O’Connor T, Moy B, Klepin HD,Chapman AE, Tew, WP, Dotan E, Fenton MA, Kim H, Kateria V, Gross CP, Cohen HJ, Muss JB, Sedrak MS.: Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial Cancer 130(6): 936-946. Mar 2024.
Disparities in care of older adults of color with cancer: A narrative review.: Dotan E, Lynch SM, Ryan JC, Mitchell EP. Cancer Med 13(3): e6790. Feb 2024.
Yankey H, Ruth KJ, Dotan E, Reddy S, Meyer J.: Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation Adv Radiat Oncol 9(4): 101412. Dec 2023.
Ioffe D. and Dotan E.: Evidence-Based Care of Older Adults With Metastatic Colorectal Cancer: Insights From Landmark Clinical Trials J Clin Oncol 41(34): 5228-5236. Dec 2023.
Fernandez SV, Tan YF, Rao S, Fittipaldi P, Sheriff F, Borghaei H, Dotan E, Winn JS, Edelman MJ, Treat J, Judd J, Alpaugh RK, Wang YL, Yu JQ, Wasik M, Baldwin DA.: Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing Int J Mol Sci 24(21): 15779. Oct 2023.